Minor
Probable
描述
Hydroxychloroquine has intrinsic insulin-sensitising properties that may augment the glucose-lowering effect of metformin, occasionally producing hypoglycaemia.
机制
Hydroxychloroquine inhibits insulin degradation in lysosomes and may improve insulin receptor sensitivity; combined with metformin's suppression of hepatic glucose output, additive hypoglycaemia can occur.
临床意义
Clinical studies in diabetic patients with rheumatoid arthritis show improved glycaemic control with hydroxychloroquine, occasionally necessitating metformin dose reduction.
处理措施
Monitor blood glucose more closely when starting or stopping hydroxychloroquine; consider reducing antidiabetic drug doses if hypoglycaemia occurs.